home image - Home

When it comes to oncology, hematology and rare disease drug development, we know what works – and what doesn’t.

As seasoned clinical drug developers, we’ve been in your shoes and have robust solutions for investor value creation.

Learn about our therapeutic experience

D2V Clinical leaders have been accountable for critical global development decisions and successful outcomes

80+


FDA Reviews

65+


Early-Phase Clinical Development Programs

5,700+


Patients

1,200+


Sites

Speed to

signal

pathway

patient

Leadership Team

Decades of experience paired with exceptional poise and oncology / rare disease knowledge

home leadership amanda@ x - Home

Amanda Fu, M.D., M.S., MBA

CO-FOUNDER AND CHIEF EXECUTIVE OFFICER

home leadership walt min - Home

Walt Cao, Ph.D.

Co-Founder, President and Regulatory Officer

home leadership vijay min - Home

Vijay Reddy, M.D.

Chief Medical Officer

home leadership jeffrey min - Home

Jeffery Roe

Executive Vice President, Human Resources

Marwa Noaman

Marwa Noaman

Clinical Operations Director

INSIGHTS

Latest News and Updates